BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34602559)

  • 1. Transduction Properties of an Adenovirus Vector Containing Sequences Complementary to a Liver-Specific microRNA, miR-122a, in the 3'-Untranslated Region of the E4 Gene in Human Hepatocytes from Chimeric Mice with Humanized Liver.
    Sakurai F; Tsukamoto T; Ono R; Nishimae F; Shiota A; Iizuka S; Shimizu K; Sakai E; Ishida Y; Tateno C; Chayama K; Mizuguchi H
    Biol Pharm Bull; 2021; 44(10):1506-1513. PubMed ID: 34602559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of a novel adenovirus vector exhibiting microRNA-mediated suppression of the leaky expression of adenovirus genes].
    Shimizu K; Sakurai F; Tachibana M; Mizuguchi H
    Yakugaku Zasshi; 2012; 132(12):1407-12. PubMed ID: 23208048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development and Characterization of a Novel Adenovirus Vector Exhibiting MicroRNA-mediated Suppression of the Leaky Expression of Adenovirus Genes].
    Shimizu K
    Yakugaku Zasshi; 2015; 135(12):1349-56. PubMed ID: 26632150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-122a-regulated expression of a suicide gene prevents hepatotoxicity without altering antitumor effects in suicide gene therapy.
    Suzuki T; Sakurai F; Nakamura S; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
    Mol Ther; 2008 Oct; 16(10):1719-26. PubMed ID: 18665157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus Vector-Induced IL-6 Promotes Leaky Adenoviral Gene Expression, Leading to Acute Hepatotoxicity.
    Shimizu K; Sakurai F; Iizuka S; Ono R; Tsukamoto T; Nishimae F; Nakamura SI; Nishinaka T; Terada T; Fujio Y; Mizuguchi H
    J Immunol; 2021 Jan; 206(2):410-421. PubMed ID: 33277385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.
    Shimizu K; Sakurai F; Tomita K; Nagamoto Y; Nakamura S; Katayama K; Tachibana M; Kawabata K; Mizuguchi H
    Mol Ther Methods Clin Dev; 2014; 1():14035. PubMed ID: 26015975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further reduction in adenovirus vector-mediated liver transduction without largely affecting transgene expression in target organ by exploiting microrna-mediated regulation and the Cre-loxP recombination system.
    Bennett D; Sakurai F; Shimizu K; Matsui H; Tomita K; Suzuki T; Katayama K; Kawabata K; Mizuguchi H
    Mol Pharm; 2012 Dec; 9(12):3452-63. PubMed ID: 23127182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of recombinant adenovirus carrying microRNA-regulated gene expression system].
    Sakurai F; Mizuguchi H
    Yakugaku Zasshi; 2010 Nov; 130(11):1497-504. PubMed ID: 21048409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-122a-Regulated Expression of a Suicide Gene Prevents Hepatotoxicity Without Altering Antitumor Effects in Suicide Gene Therapy.
    Suzuki T; Sakurai F; Nakamura SI; Kouyama E; Kawabata K; Kondoh M; Yagi K; Mizuguchi H
    Mol Ther; 2008 Oct; 16(10):1719-1726. PubMed ID: 28189004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of hepatitis C virus replicon by adenovirus vector-mediated expression of tough decoy RNA against miR-122a.
    Sakurai F; Furukawa N; Higuchi M; Okamoto S; Ono K; Yoshida T; Kondoh M; Yagi K; Sakamoto N; Katayama K; Mizuguchi H
    Virus Res; 2012 May; 165(2):214-8. PubMed ID: 22342424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA silencing improves the tumor specificity of adenoviral transgene expression.
    Card PB; Hogg RT; Gil Del Alcazar CR; Gerard RD
    Cancer Gene Ther; 2012 Jul; 19(7):451-9. PubMed ID: 22555510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
    Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
    Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
    Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
    Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of HSVtk gene by endogenous microRNA-122a in liver cell lines as suicide gene therapy.
    Ghanbari M; Saberfar E; Goodarzi Z; Lashini H; Ghanbari S; Karamimanesh M; Baesi K
    Gastroenterol Hepatol Bed Bench; 2017; 10(3):202-207. PubMed ID: 29118936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the inflammatory properties and hepatotoxicity of recombinant adenovirus vectors by the viral E4 gene products.
    Christ M; Louis B; Stoeckel F; Dieterle A; Grave L; Dreyer D; Kintz J; Ali Hadji D; Lusky M; Mehtali M
    Hum Gene Ther; 2000 Feb; 11(3):415-27. PubMed ID: 10697116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of first generation E1E3-deleted and second generation E1E3E4-deleted/modified adenovirus vectors on human endothelial cell death.
    Jornot L; Petersen H; Lusky M; Pavirani A; Moix I; Morris ; Rochat T
    Endothelium; 2001; 8(3):167-79. PubMed ID: 11824470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the E4 region on the persistence of transgene expression from adenovirus vectors.
    Armentano D; Zabner J; Sacks C; Sookdeo CC; Smith MP; St George JA; Wadsworth SC; Smith AE; Gregory RJ
    J Virol; 1997 Mar; 71(3):2408-16. PubMed ID: 9032378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two key challenges for effective adenovirus-mediated liver gene therapy: innate immune responses and hepatocyte-specific transduction.
    Descamps D; Benihoud K
    Curr Gene Ther; 2009 Apr; 9(2):115-27. PubMed ID: 19355869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of the Adenovirus Vector-Mediated CRISPR/Cpf1 System and the Application for Primary Human Hepatocytes Prepared from Humanized Mice with Chimeric Liver.
    Tsukamoto T; Sakai E; Iizuka S; Taracena-Gándara M; Sakurai F; Mizuguchi H
    Biol Pharm Bull; 2018; 41(7):1089-1095. PubMed ID: 29962404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.